Five biopharmaceutical manufacturing execs share the trends and innovations they are paying closest attention to and why.
Four biopharmaceutical execs weigh if geographic proximity (e.g., being in a major biopharma hub) is as important today as it once was.
Three biopharmaceutical executives share perspectives on how the industry might look in the next decade.
Nine biopharmaceutical CEOs share thoughts on the key trends they are paying attention to and why.
Lisa Conte, founder and CEO of Jaguar Health, shares her wisdom from corporate collaboration lessons learned the hard way.
Lisa Conte, founder of Jaguar Health, shares her thoughts on becoming a biopharmaceutical company CEO, and the approach taken to create the proper corporate culture.
Michael Byrnes, CFO at eFFECTOR Therapeutics, provides a prequel to an upcoming two-part article in Life Science Leader, with some specific recommendations for executive teams on SPACs.
Nobert Bischofberger, Ph.D., CEO of Kronos Bio, reflects on lessons learned from an important mentor and biotech icon.
Laura Niklason, M.D., Ph.D., cofounder and CEO of Humacyte, explains some of the science of her regenerative medicines company so to be public via a SPAC.
A primer on what makes Eric Dube, Ph.D., CEO of Travere Therapeutics and upcoming feature in Life Science Leader, so inspirational.
Get the latest articles from Life Science Leader delivered to your inbox.